Aspirin plus ticlopidine prevented experimental endocarditis due to Enterococcus faecalis and Streptococcus gallolyticus.
Fiche du document
2015
- doi: 10.1093/femspd/ftv060
- issn: 2049-632X
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1093/femspd/ftv060
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/26310867
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/2049-632X
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_61D89C363FF60
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
Sujets proches
Chlorobenzyltetrahydrothienopyridine Chlorophenylmethyltetrahydrothienopyridine Acetylsalicylic acidCiter ce document
T.R. Veloso et al., « Aspirin plus ticlopidine prevented experimental endocarditis due to Enterococcus faecalis and Streptococcus gallolyticus. », Serveur académique Lausannois, ID : 10.1093/femspd/ftv060
Métriques
Partage / Export
Résumé
Enterococcus faecalis and Streptococcus gallolyticus cause infective endocarditis (IE), which can originate from the continuous release or translocation of low bacterial numbers into the bloodstream. In this context, IE cannot be prevented with antibiotics. We previously demonstrated that aspirin plus ticlopidine protected rats from IE due to S. gordonii and Staphylococcus aureus. Here we showed that aspirin plus ticlopidine significantly reduced vegetation weight and protected 73 and 64% rats (P < 0.005) from IE due to E. faecalis and S. gallolyticus, respectively. These results further support the potential use of aspirin plus ticlopidine for a global prevention of IE in high-risk patients.